Dr Reddy's Labs' new head for Europe Generics

Dr Reddy's Laboratories Limited today announced the appointment of Alan Sheppard as executive vice-president and head of its Europe Generics and as managing director and head of Dr Reddy's UK Limited.

Sheppard will be responsible for the management of the company's generics business in Europe and will be based in the UK.

Sheppard joins Dr Reddy's from Pliva, a leading European pharmaceutical company, where he was vice president for Global Corporate Strategy. He had previously been vice-president, Western Europe, where he was responsible for establishing Pliva's business in the European Union.

He has also served as general manager of Rhone-Poulenc Rorer (now Aventis); European marketing director for Medeva and held various positions with Institute Merieux, Smith Kline and Upjohn.

GV Prasad, CEO of Dr Reddy's Laboratories, said, "Having been in the pharmaceutical industry since 1971, Sheppard brings with him a wealth of experience, which includes commercial, general management, R&D, manufacturing and strategic planning across generics, ethical branded, OTC and vaccines. Dr Reddy's will leverage this experience in taking our business forward in Europe."

According to a press release, Sheppard has served on several UK Government committees and has been a long standing member of the Association of British Pharmaceutical Industry's Code of Practice Committee, which regulates the promotion of medicines. He is also an honorary lecturer at the University of Wales.